{"log_id": 1767254273109853107, "direction": 0, "words_result_num": 37, "words_result": [{"probability": {"variance": 6e-06, "average": 0.998495, "min": 0.991809}, "location": {"width": 209, "top": 315, "height": 34, "left": 218}, "words": "皮肤和皮下组织紊乱"}, {"probability": {"variance": 0.000107, "average": 0.994705, "min": 0.966992}, "location": {"width": 317, "top": 343, "height": 37, "left": 219}, "words": "常见:皮疹(包括红斑和瘙痒)"}, {"probability": {"variance": 0, "average": 0.999364, "min": 0.998406}, "location": {"width": 184, "top": 406, "height": 28, "left": 221}, "words": "肾脏和泌尿道紊乱"}, {"probability": {"variance": 0, "average": 0.999486, "min": 0.998103}, "location": {"width": 117, "top": 439, "height": 26, "left": 221}, "words": "常见:多尿"}, {"probability": {"variance": 5.1e-05, "average": 0.996502, "min": 0.973644}, "location": {"width": 278, "top": 490, "height": 35, "left": 221}, "words": "全身性紊乱及给药部位情况"}, {"probability": {"variance": 2e-06, "average": 0.998756, "min": 0.996224}, "location": {"width": 182, "top": 524, "height": 28, "left": 222}, "words": "常见:无力、水肿"}, {"probability": {"variance": 4e-06, "average": 0.998778, "min": 0.994236}, "location": {"width": 164, "top": 580, "height": 28, "left": 222}, "words": "实验室检查结果"}, {"probability": {"variance": 0.00122, "average": 0.988115, "min": 0.868817}, "location": {"width": 570, "top": 599, "height": 43, "left": 222}, "words": "常见:可逆性碱性磷酸脂酶升高(临床显著增加不常见)"}, {"probability": {"variance": 0, "average": 0.722666, "min": 0.722666}, "location": {"width": 40, "top": 684, "height": 38, "left": 47}, "words": "○"}, {"probability": {"variance": 0, "average": 0.999491, "min": 0.998346}, "location": {"width": 83, "top": 678, "height": 27, "left": 231}, "words": "【禁忌】"}, {"probability": {"variance": 2e-06, "average": 0.998928, "min": 0.993478}, "location": {"width": 359, "top": 705, "height": 34, "left": 291}, "words": "对本品中任何成分过敏的患者禁用"}, {"probability": {"variance": 0.000882, "average": 0.9886, "min": 0.867499}, "location": {"width": 508, "top": 736, "height": 39, "left": 293}, "words": "与其它二氢吡啶类药物一样,拉西地平禁用于严"}, {"probability": {"variance": 0.025952, "average": 0.871886, "min": 0.644558}, "location": {"width": 102, "top": 737, "height": 32, "left": 867}, "words": "脉瓣窄"}, {"probability": {"variance": 0, "average": 0.843979, "min": 0.843979}, "location": {"width": 29, "top": 778, "height": 27, "left": 223}, "words": "人"}, {"probability": {"variance": 0, "average": 0.817121, "min": 0.817121}, "location": {"width": 72, "top": 747, "height": 76, "left": 785}, "words": "品"}, {"probability": {"variance": 0, "average": 0.999782, "min": 0.999475}, "location": {"width": 128, "top": 842, "height": 29, "left": 232}, "words": "【注意事项】"}, {"probability": {"variance": 0.000497, "average": 0.994379, "min": 0.876675}, "location": {"width": 728, "top": 866, "height": 40, "left": 293}, "words": "特异性研究显示,拉西地平不影响窦房结的自律性,不会导致房室结"}, {"probability": {"variance": 0.000124, "average": 0.996761, "min": 0.93524}, "location": {"width": 795, "top": 896, "height": 41, "left": 225}, "words": "内传导时间延长。但应注意钙离子拮抗剂理论上对窦房结和房室结活性的影"}, {"probability": {"variance": 0.000391, "average": 0.993782, "min": 0.904356}, "location": {"width": 522, "top": 928, "height": 39, "left": 226}, "words": "响。因此,窦房结和房室结活性异常患者慎用本品"}, {"probability": {"variance": 0.000154, "average": 0.996189, "min": 0.931427}, "location": {"width": 724, "top": 960, "height": 38, "left": 296}, "words": "正如报道的其它二氢吡啶钙通道拮抗剂,拉西地平应谨慎应用于先天"}, {"probability": {"variance": 6.2e-05, "average": 0.997321, "min": 0.955627}, "location": {"width": 798, "top": 990, "height": 41, "left": 223}, "words": "性或已确认的获得性QT延长的患者。同时服用已知可延迟QT间期的药"}, {"probability": {"variance": 0.008977, "average": 0.970389, "min": 0.565435}, "location": {"width": 799, "top": 1021, "height": 41, "left": 224}, "words": "物,如I型和II型抗心律失常药、三环类抗抑郁剂、某些抗精神病药物、抗"}, {"probability": {"variance": 0.001582, "average": 0.986029, "min": 0.804969}, "location": {"width": 723, "top": 1050, "height": 41, "left": 226}, "words": "生素(如红霉素)和某些抗组胺药(如特非那定)的患者,应慎用拉西地平"}, {"probability": {"variance": 1.3e-05, "average": 0.997796, "min": 0.985538}, "location": {"width": 594, "top": 1086, "height": 37, "left": 297}, "words": "与其他钙离子拮抗剂一样,心脏储备力差的患者慎用本品"}, {"probability": {"variance": 0.001633, "average": 0.987058, "min": 0.797863}, "location": {"width": 726, "top": 1119, "height": 40, "left": 296}, "words": "与其他二氢吡啶类钙离子拮抗剂一样,患有不稳定心绞痛的患者服用"}, {"probability": {"variance": 1e-06, "average": 0.999175, "min": 0.997357}, "location": {"width": 141, "top": 1160, "height": 27, "left": 228}, "words": "本品时应小心"}, {"probability": {"variance": 0.000251, "average": 0.994589, "min": 0.933695}, "location": {"width": 381, "top": 1187, "height": 37, "left": 296}, "words": "新近曾发生心肌梗塞的患者慎用本品"}, {"probability": {"variance": 5e-06, "average": 0.998732, "min": 0.99079}, "location": {"width": 725, "top": 1218, "height": 40, "left": 298}, "words": "由于肝功能损伤的患者服用本品可能出现抗高血压的作用被加强因"}, {"probability": {"variance": 1e-06, "average": 0.998906, "min": 0.996489}, "location": {"width": 309, "top": 1254, "height": 36, "left": 228}, "words": "此肝功能损伤的患者慎用本品"}, {"probability": {"variance": 2e-06, "average": 0.998856, "min": 0.995367}, "location": {"width": 573, "top": 1285, "height": 39, "left": 297}, "words": "没有证据显示拉西地平降低糖耐量或改变糖尿病的控制"}, {"probability": {"variance": 0.000123, "average": 0.996048, "min": 0.959348}, "location": {"width": 275, "top": 1358, "height": 36, "left": 237}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 9e-06, "average": 0.998231, "min": 0.987208}, "location": {"width": 379, "top": 1391, "height": 35, "left": 299}, "words": "尚无拉西地平用于孕妇的安全性数据"}, {"probability": {"variance": 3.9e-05, "average": 0.99654, "min": 0.973999}, "location": {"width": 524, "top": 1422, "height": 41, "left": 300}, "words": "动物实验显示拉西地平没有致畸性和对生长的损害"}, {"probability": {"variance": 8.2e-05, "average": 0.995304, "min": 0.965754}, "location": {"width": 609, "top": 1459, "height": 39, "left": 300}, "words": "动物乳汁分泌实验表明,拉西地平(或其代谢物)可泌入乳汁"}, {"probability": {"variance": 3e-06, "average": 0.998401, "min": 0.992596}, "location": {"width": 725, "top": 1493, "height": 40, "left": 300}, "words": "妊娠和哺乳期间,只有在预期对母亲的益处超过任何对胎儿或新生儿"}, {"probability": {"variance": 0.001373, "average": 0.986417, "min": 0.869403}, "location": {"width": 265, "top": 1530, "height": 34, "left": 231}, "words": "的可能危害时才考虑用药"}, {"probability": {"variance": 4.1e-05, "average": 0.997468, "min": 0.969696}, "location": {"width": 499, "top": 1560, "height": 36, "left": 301}, "words": "应考虑本品在孕晚期引起子宫肌肉松弛的可能性"}], "language": 3}